An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...

A national study finds technology use and blood sugar control are up in youths and adults with type 1 diabetes, yet racial, ...

Jason Bergsbaken, PharmD, MBA, BCOP, explains the value of pharmacist involvement in precision molecular tumor boards and end-of-life care discussions, highlighting their role in ensuring ...

Elise S. Tremblay, MD, MPH, explores potential policy solutions and research directions to address ongoing challenges in insulin affordability and access.

Clayton Irvine, PharmD, MBA, MS, discusses strategies to address payer-driven biosimilar and prior authorization challenges through integrated digital solutions, while advocating for flexible, ...

An expert discusses the importance of balancing efficacy with safety in ITP treatment, emphasizing cautious use of steroids, close monitoring of therapy-related side effects, and maintaining platelet ...

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and ...

Hair and scalp disorders in patients with skin of color are frequently misdiagnosed, often due to educational gaps and ...

Individuals who used smokeless tobacco and e-cigarettes had an increased risk of developing age-related macular degeneration ...

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

Physicians were more likely to include terms that undermine the competence and sincerity of Black patients' claims when ...

DYNE-251 received FDA breakthrough therapy designation, showcasing its potential for patients with Duchenne muscular ...